Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis
Masabho P. Milali(New York University), Anna Bershteyn(New York University), David Kaftan(New York University), Danielle Resar(Clinton Health Access Initiative), Ingrida Platais(New York University), Jennifer Campbell(Clinton Health Access Initiative), Hae‐Young Kim(New York University), Adebanjo Olowu(Clinton Health Access Initiative), Danny Edwards(Clinton Health Access Initiative), Sarah M. Jenkins(Mayo Clinic)
Cited by 10
Related Papers
The Magnetic Genome of Two-Dimensional van der Waals Materials
|ACS Nano|2022|475
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
|Neurology|2013|241
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
|JAMA Neurology|2021|218